Mechanisms of matrix metalloproteinase-2 (mmp-2) transcriptional repression by progesterone in jar choriocarcinoma cells

Reproductive Biology and Endocrinology

Volumn 7, Issue , 2009, Pages

  Goldman, Shlomit ^a   Lovett, David H ^b   Shalev, Eliezer ^a,c  

^a HAEMEK MEDICAL CENTER   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GELATINASE A; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MATRIX METALLOPROTEINASE; NUCLEAR PROTEIN; OLIGONUCLEOTIDE; PRO MATRIX METALLOPROTEINASE 2; PROGESTERONE; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP2; TRANSCRIPTION FACTOR SP3; TRANSCRIPTION FACTOR SP4; UBIQUITIN; UNCLASSIFIED DRUG; SP4 PROTEIN, HUMAN;

ARTICLE; BINDING SITE; CHORIOCARCINOMA; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REPRESSION; GEL MOBILITY SHIFT ASSAY; GENE DELETION; HUMAN; HUMAN CELL; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE BINDING SITE; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TUMOR CELL LINE; ZYMOGRAPHY; ANIMAL; DNA RESPONSIVE ELEMENT; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; UTERUS CANCER;

RATTUS;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CHORIOCARCINOMA; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MOLECULAR SEQUENCE DATA; PROGESTERONE; PROMOTER REGIONS, GENETIC; RATS; RECEPTORS, PROGESTERONE; RESPONSE ELEMENTS; SP1 TRANSCRIPTION FACTOR; SP4 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; UTERINE NEOPLASMS;

EID: 66749182263     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-7-41     Document Type: Article

References (42)

1. Turpeenniemi-Hujanen T Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers Biochimie 2005, 87:287-297. 10.1016/j.biochi.2005.01.014 15781315
2. Li Q Xu W Novel anticancer targets and drug discovery in post genomic age Curr Med Chem Anticancer Agents 2005, 5:53-63. 10.2174/ 1568011053352631 15720261
3. Honkavuori M Talvensaari-Mattila A Soini Y Turpeenniemi-Hujanen T Santala M MMP-2 expression associates with CA 125 and clinical course in endometrial carcinoma Gynecol Oncol 2007, 104:217-221. 10.1016/ j.ygyno.2006.08.006 16996112
4. Graesslin O Cortez A Uzan C Birembaut P Quereux C Daraï E Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions Int J Gynecol Cancer 2006, 16:1911-1917. 10.1111/j.1525-1438.2006.00717.x 17009991
5. Sillanpää S Anttila M Suhonen K Hämäläinen K Turpeenniemi-Hujanen T Puistola U Tammi M Sironen R Saarikoski S Kosma VM Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer Tumour Biol 2007, 28:280-289. 10.1159/000110426 17962725
6. Di Simone N Di Nicuolo F Sanguinetti M Castellani R D'Asta M Caforio L Caruso A Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes J Endocrinol 2006, 89:691-699. 10.1677/joe.1.06610
7. Goldman S Shalev E Difference in progesterone-receptor isoforms ratio between early and late first-trimester human trophoblast is associated with differential cell invasion and matrix metalloproteinase 2 expression Biol Reprod 2006, 74:13-22. 10.1095/biolreprod.105.044925 16135696
8. Bischof P Endocrine, paracrine and autocrine regulation of trophoblastic metalloproteinases Early Pregnancy 2001, 5:30-31. 11753501
9. Choi HK Choi BC Lee SH Kim JW Cha KY Baek KH Expression of angiogenesis- and apoptosis-related genes in chorionic villi derived from recurrent pregnancy loss patients Mol Reprod Dev 2003, 66:24-31. 10.1002/mrd.10331 12874795
10. Mahameed S Goldman S Gabarin D Weiss A Shalev E The effect of serum from women with preeclampsia on JAR (trophoblast-like) cell line J Soc Gynecol Investig 2005, 12:45-50. 10.1016/j.jsgi.2005.06.002
11. Petignat P Laurini R Goffin F Bruchim I Bischof P Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta Int J Gynecol Cancer 2006, 16:1679-1684. 10.1111/j.1525-1438.2006.00643.x 16884384
12. Yonemoto H Young CB Ross JT Guilbert LL Fairclough RJ Olson DM Changes in matrix metalloproteinase (MMP)-2 and MMP-9 in the fetal amnion and chorion during gestation and at term and preterm labor Placenta 2006, 27:669-677. 10.1016/j.placenta.2005.05.014 16061282
13. Shah BH Catt KJ Matrix metalloproteinases in reproductive endocrinology Trends Endocrinol Metab 2004, 15:47-49. 10.1016/j.tem.2004.01.004 15080147
14. Cheng S Alfonso-Jaume MA Mertens PR Lovett DH Tumour metastasis suppressor, nm23-beta, inhibits gelatinase A transcription by interference with transactivator Y-box protein-1 (YB-1) Biochem J 2002, 366:807-816. 1222814 12010125
15. Bergman MR Cheng S Honbo N Piacentini L Karliner JS Lovett DH A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase-2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers Biochem J 2003, 369:485-496. 1223099 12371906 10.1042/BJ20020707
16. Mertens PR Steinmann K Alsonso-Jaume MA En-Nia A Sun Y Lovett DH Combinatorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells J Biol Chem 2002, 277:24875-24882. 10.1074/jbc.M200445200 11973333
17. Mertens PR Harendza S Pollock AS Lovett DH Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1 J Biol Chem 1997, 272:22905-22912. 10.1074/jbc.272.36.22905 9278454
18. Qin H Sun Y Benveniste EN The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells J Biol Chem 1999, 274:29130-29137. 10.1074/ jbc.274.41.29130 10506168
19. Bian J Sun Y Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter Mol Cell Biol 1997, 17:6330-6338. 232484 9343394
20. Wingrove CS Garr E Godsland IF Stevenson JC 17beta-oestradiol enhances relase of matrix metalloproteinase-2 from human vascular smooth muscle cells Biochim Biophys Acta 1998, 1406:169-174. 9573355
21. Guccione M Silbiger S Lei J Neugarten J Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2 Am J Physiol Renal Physiol 2002, 282(1):F164-F169. 11739124
22. Puistola U Westerlund A Kauppila A Turpeenniemi-Hujanen T Regulation of 72-kd type IV collagenase-matrix metalloproteinase-2 by estradiol and gonadotropin-releasing hormone agonist in human granulose-lutein cells Fertil Steril 1995, 64:81-87. 7789584
23. Harendza S Lovett DH Panzer U Lukacs Z Kuhnl P Stahl RA Linked common polymorphoisms in the gelatinase A promoter are associated with diminished transcriptional response to estrogen and genetic fitness J Biol Chem 2003, 278:20490-20499. 10.1074/jbc.M211536200 12657623
24. Goldman S Weiss A Shalev E The effect of progesterone on gelatinase expression in the decidua and fetal membranes before and after contractions Am J Obstet Gynecol 2007, 197:521.e1-521.e7. 10.1016/ j.ajog.2007.03.075
25. Zhang J Hampton AL Nie G Salamonsen LA Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium Biol Reprod 2000, 62:85-94. 10.1095/biolreprod62.1.85 10611071
26. Sumida T Itahana Y Hamakawa H Desprez PY Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins Cancer Res 2004, 64:7886-7892. 10.1158/0008-5472.CAN-04-1155 15520195
27. Saito T Mizumoto H Tanaka R Satohisa S Adachi K Horie M Kudo R Overexpressed progesterone receptor form B inhibit invasive activity suppressing matrix metalloproteinases in endometrial carcinoma cells Cancer Lett 2004, 209:237-243. 10.1016/j.canlet.2003.12.017 15159027
28. Decruze SB Green JA Hormone therapy in advanced and recurrent endometrial cancer: A systematic review Int J Gynecol Cancer 2007, 17:964-978. 17442022
29. Szekeres-Bartho J Wilczynski JR Basta P Kalinka J Role of progesterone and progestin therapy in threatened abortion and preterm labour Front Biosci 2008, 13:1981-1990. 10.2741/2817 17981685
30. Proctor A Hurst BS Marshburn PB Matthews ML Effect of progesterone supplementation in early pregnancy on the pregnancy outcome after in vitro fertilization Fertil Steril 2006, 85:1550-1552. 10.1016/ j.fertnstert.2005.10.060 16603159
31. Bailit JL Votruba ME Medical cost savings associated with 17 alpha-hydroxyprogesterone caproate Am J Obstet Gynecol 2007, 196:e1-7. 10.1016/j.ajog.2006.12.021 17346527
32. TESS Transcription Element Search System http://www.cbil.upenn.edu/ cgi-bin/tess
33. Schweppe KW Long-term use of progestogens - effects on endometriosis, adenomyosis and myomas Gynecol Endocrinol 2007, 23:17-21. 10.1080/ 09513590701584923 17943535
34. Leonhardt SA Boonyaratanakornkit V Edwards DP Progesterone receptor transcription and non-transcription signaling mechanisms Steroids 2003, 68:761-770. 10.1016/S0039-128X(03)00129-6 14667966
35. Conneely OM Mulac-Jericevic B Lydon JP Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms Steroids 2003, 68:771-778. 10.1016/S0039-128X(03)00126-0 14667967
36. Li X O'Malley BW Unfolding the action of progesterone receptors J Biol Chem 2003, 278:39261-39264. 10.1074/jbc.R300024200 12893816
37. Cheng YH Imir A Suzuki T Fenkci V Yilmaz B Sasano H Bulun SE SP1 and SP3 mediate progesterone-dependent induction of the 17beta hydroxysteroid dehydrogenase type 2 gene in human endometrium Biol Reprod 2006, 75:605-614. 10.1095/biolreprod.106.051912 16807381
38. Zhang XL Zhang D Michel FJ Blum JL Simmen FA Simmen RC Selective interactions of Kruppel-like factor 9/basic transcription element-binding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cells J Biol Chem 2003, 278:21474-21482. 10.1074/ jbc.M212098200 12672823
39. Christian M Pohnke Y Kempf R Gellersen B Brosens JJ Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells Mol Endocrinol 2002, 16:141-154. 10.1210/ me.16.1.141 11773445
40. Shupnik MA Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: Implications for cell proliferation Oncogene 2004, 23:7979-7989. 10.1038/sj.onc.1208076 15489915
41. Shatnawi A Tran T Ratnam M R5020 and RU486 act as progesterone receptor agonists to enhance Sp1/Sp4-dependent gene transcription by an indirect mechanism Mol Endocrinol 2007, 21:635-650. 10.1210/me.2006-0274 17192405
42. Abdelrahim M Safe S Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins Mol Pharmacol 2005, 68:317-329. 15883203